Croda International Plc (LON:CRDA – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six brokerages that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is GBX 3,140.
Several research firms have recently weighed in on CRDA. Deutsche Bank Aktiengesellschaft cut their price objective on Croda International from GBX 3,100 to GBX 3,000 and set a “hold” rating on the stock in a report on Tuesday. Morgan Stanley upgraded shares of Croda International to an “overweight” rating and raised their target price for the stock from GBX 3,280 to GBX 3,350 in a report on Wednesday.
Get Our Latest Stock Report on Croda International
Croda International Stock Performance
Croda International (LON:CRDA – Get Free Report) last posted its earnings results on Tuesday, February 24th. The company reported GBX 146.20 earnings per share (EPS) for the quarter. Croda International had a return on equity of 2.82% and a net margin of 3.65%. On average, research analysts predict that Croda International will post 181.8307268 EPS for the current year.
Insider Transactions at Croda International
In related news, insider Danuta Gray acquired 750 shares of the stock in a transaction dated Friday, March 6th. The stock was bought at an average price of GBX 2,788 per share, with a total value of £20,910. Also, insider Steve Foots sold 3,622 shares of the firm’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of GBX 2,606, for a total transaction of £94,389.32. Insiders purchased 766 shares of company stock valued at $2,136,858 over the last quarter. Corporate insiders own 0.83% of the company’s stock.
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Read More
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
